Medical devices, healthcare technology and the business of care
PMA approval · P810006

COLLASTAT

Integra LifeSciences Corporation · Decision date Dec 10, 1981

FDA DECISIONP810006

What did the FDA approve?

FDA records P810006 as an original PMA application. The recorded decision is approval, dated Dec 10, 1981.

An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.

Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Dec 10, 1981

FDA source record

Regulatory record facts

Identifier
P810006
Regulatory pathway
Premarket approval application
Product code
LMF
Decision code
APPR
Decision date
Dec 10, 1981
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Agent, absorbable hemostatic, collagen based.

Product code
LMF
FDA device class
3

FDA decision timeline

  1. P810006 received

    Application receipt date recorded by FDA.

  2. P810006 · FDA decision

    APPR

  3. P810006/S115 · Related supplement

    Collastat Absorbable Collagen Hemostatic Sponge and Collastat Absorbable Collagen Hemostatic Agent - Microfibrillar Fo

Timeline entries are records held by MedtechLedger for P810006. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P810006

Explore the linked device profile

Other records with product code LMF

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Integra LifeSciences Corporation

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
311 Enterprise Dr., Planisboro, NJ, 08536

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records
P810006: COLLASTAT | MedtechLedger